Prednison acis 5 mg clinical trials
3 indexed studies · 0 currently recruiting
- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Single-Dose Two-Period Crossover Study to Assess the Effect of Food on MK-5684 Pharmacokinetics and to Monitor Pharmacodynamic Effects Over Time in Healthy Participants
This study looks at how a new medicine, MK-5684, behaves in healthy men when taken with or without food. It also checks how the medicine affects certain hormone levels over time. This early research helps scientists understand the drug before testing it in patients with advanced prostate cancer.
For: refractory metastatic prostate cancerBelgium - Ongoing, recruitingPhase I and Phase II (Integrated)- Other
Phase 1/2 Dose Finding, Safety and Efficacy Study of Ibrutinib in Pediatric Subjects with Chronic Graft Versus Host Disease (cGVHD)
This study is looking at a medicine called ibrutinib for children and young people with chronic Graft Versus Host Disease (cGVHD). It aims to find the right dose and check how safe and effective it is for those aged 1 to 22 years.
For: Chronic Graft Versus Host Disease (cGVHD)France · Italy · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
This study is testing a new eye treatment called JNJ-81201887 for a condition called Geographic Atrophy (GA). GA is a serious eye problem linked to ageing that can cause blurry vision. Researchers want to see if this new treatment can slow down the worsening of GA.
For: Geographic AtrophyNetherlands · Belgium · Germany